Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Healthcare Services (HCSG) EBITDA Margin (2016 - 2025)

Healthcare Services (HCSG) has disclosed EBITDA Margin for 17 consecutive years, with 6.76% as the latest value for Q4 2025.

  • On a quarterly basis, EBITDA Margin rose 444.0% to 6.76% in Q4 2025 year-over-year; TTM through Dec 2025 was 8.4%, a 315.0% increase, with the full-year FY2025 number at 3.32%, up 104.0% from a year prior.
  • EBITDA Margin was 6.76% for Q4 2025 at Healthcare Services, up from 3.96% in the prior quarter.
  • In the past five years, EBITDA Margin ranged from a high of 6.76% in Q4 2025 to a low of 1.96% in Q3 2023.
  • A 5-year average of 2.8% and a median of 2.58% in 2021 define the central range for EBITDA Margin.
  • Peak YoY movement for EBITDA Margin: plummeted -557bps in 2021, then skyrocketed 572bps in 2024.
  • Healthcare Services' EBITDA Margin stood at 1.14% in 2021, then surged by 267bps to 4.2% in 2022, then surged by 49bps to 6.24% in 2023, then tumbled by -63bps to 2.31% in 2024, then skyrocketed by 192bps to 6.76% in 2025.
  • Per Business Quant, the three most recent readings for HCSG's EBITDA Margin are 6.76% (Q4 2025), 3.96% (Q1 2025), and 2.31% (Q4 2024).